8 completed, 3 unknown, 1 recruiting, 1 withdrawn. 13 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 8, Unknown 3, Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Fungal Infection: new trials by email Literature Review of Fungal Infection trials Research Report on Fungal Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy | Phase 2 | Recruiting | The University of Queensland | 104 | 2025-04-14 | 2026-04-16 |
| A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail BB2603-1, BB2603-3, BB2603-10 - Distal Subungual Onychomycosis, Fungal Infection | Phase 2 | Completed | Blueberry Therapeutics | 111 | 2021-03-22 | 2023-08-01 |
| Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Escalating prophylaxis - Fungal Infection | Phase 2 | Unknown | Shanghai Jiao Tong University School of Medicine | 175 | 2020-01-15 | 2021-11-26 |
| Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin Caspofungin - Fungal Infection | Phase 2 | Completed | Cttq | 32 | 2018-09-17 | 2021-07-07 |
| Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant Universal Posaconazole Prophylaxis, Pre-emptive Posaconazole Therapy - Fungal Infection | Phase 2 | Unknown | Bayside Health | 140 | 2018-07-02 | 2018-06-19 |
| Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole Conditioning treatment "Thiotepa-Treosulfan-Fludarabine", PBSC graft, GvHD prophylaxis - Transplant-Related Hematologic Malignancy, Leukemia, Acute | Phase 2 | Completed | Ciceri Fabio | 10 | 2018-06-18 | 2022-07-19 |
| Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients Posaconazole - Aplastic Anemia, Myelodysplastic Syndromes | Phase 2 | Completed | Seoul National University Hospital | 20 | 2018-04-20 | 2024-12-20 |
| CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension CD101, Caspofungin, Fluconazole - Candidemia, Mycoses | Phase 2 | Completed | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 207 | 2016-07-26 | 2020-12-08 |
| Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis caspofungin - Fungal Infection | Phase 2 | Completed | Werner J. Heinz | 25 | 2011-04-01 | 2014-01-09 |
| Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia Posaconazole - Leukemia, Fungal Infection | Phase 2 | Completed | M.D. Anderson Cancer Center | 25 | 2009-09-01 | 2019-02-27 |
| Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients human lactoferrin (hLF1-11) - Fungal Infection, Bacterial Infection | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2008-11-01 | 2015-06-30 | |
| Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) caspofungin acetate - Fungal Infection | Phase 2 | Completed | Merck Sharp & Dohme LLC | 16 | 2004-05-01 | 2017-02-23 |
| Prophylaxis With Caspofungin in High-Risk Liver Transplantation Caspofungin - Liver Transplantation, Fungal Infection | Phase 2 | Unknown | Grupo de Estudio de Infecciones en Transplantados | 70 | 2003-10-01 | 2007-04-13 |
Mycoses (13) · Infections (2) · Leukemia (2) · Myelodysplastic Syndromes (2) · Anemia, Aplastic (1) · Aspergillosis (1) · Bacterial Infections (1) · Bone Marrow Neoplasms (1) · Candidemia (1) · Candidiasis, Invasive (1) · Communicable Diseases (1) · Fungemia (1) · Graft vs Host Disease (1) · Hematologic Neoplasms (1) · Invasive Fungal Infections (1)
Bacterial Infections and Mycoses (13) · Infections (11) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Bone Marrow Diseases (3) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Agranulocytosis (1) · Anemia (1) · Bone Marrow Failure Disorders (1) · Candidiasis (1) · Cytopenia (1)
Caspofungin (5) · posaconazole (2) · Fluconazole (1) · Injections (1)
AM-Pharma (1) · Bayside Health (1) · Blueberry Therapeutics (1) · Ciceri Fabio (1) · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Cttq (1) · Grupo de Estudio de Infecciones en Transplantados (1) · M.D. Anderson Cancer Center (1) · Merck Sharp & Dohme LLC (1) · Seoul National University Hospital (1) · Shanghai Jiao Tong University School of Medicine (1) · The University of Queensland (1) · Werner J. Heinz (1)
United States (3) · Australia (2) · China (2) · Germany (2) · Italy (2) · Spain (2) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Greece (1) · Hungary (1) · Netherlands (1) · Poland (1) · Romania (1)
Jason A Roberts, PhD (1) · Jesus Fortun, MD (1) · Jianda Hu, Ph.D (1) · Jiong Hu (1) · Jorge Cortes, MD (1) · Orla Morrissey (1) · Peter J Donnelly, PhD (1) · Taylor Sandison, MD MPH (1) · Werner J Heinz, MD (1)
PMID 32955088, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006
2009 (1), 2015 (1), 2017 (1)